Corporate calendar for Celularity Inc. (CELU): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Celularity Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering "off-the-shelf" allogeneic cell therapies, which are developed from placental sources. These innovative treatments are designed to combat a range of serious conditions, including various cancers, immune system dysfunctions, and infectious diseases. The company’s operations are segmented into three distinct areas: Cell Therapy, Degenerative Disease, and BioBanking.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-14 | $0.03 | $3M |
| 2026-09-14 | ||
| 2026-09-14 | $0.18 | $557M |
| 2026-09-14 | ||
| 2026-09-14 | $1M | |
| 2026-09-14 |
Stock Splits
| Date | Ratio |
|---|---|
| 2024-02-29 | 1:10 |
Price
| Price | $1.29 |
| Market Cap | $37M |
| Exchange | NASDAQ |
| Country | US |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 3 |
| Hold | 2 |
| Sell | 1 |
| Strong Sell | 0 |
| Total analysts | 6 |
| Avg rating (1-5) | 0.33 |
Related companies: ANVS · ATNM · BCAB · BTAI · FGEN · GBIO · KZR
Explore sector: Healthcare · Biotechnology
More sections of CELU: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks